When does unlimited cure extension discretion in a private lending fund's loan docs become a red flag
Reading a private lender fund's sample note and mortgage as a prospective LP, a structure like this is worth flagging: a 15 day grace period, then written notice of default, then a 30 day cure, with the operating agreement giving the manager discretion to extend cure periods to preserve borrower relationships, with no cap stated on that discretion. On a 12 month bridge loan at 11 percent with 3 points, senior secured at 70 LTV on paper, unlimited cure discretion means the manager can leave a non-performing loan on the books indefinitely while continuing to mark it at par, and investor distributions during that period could be coming from interest actually collected, from new investor capital, or from reserves, with no way to tell which from the loan documents alone. Some cure flexibility is normal in private lending, since forcing every technical default straight to foreclosure destroys value for everyone. But discretion with no outer limit, combined with no disclosure requirement tying distributions to actual collections versus reserves, is a real flag rather than standard practice. The disclosure that actually answers the question is a monthly or quarterly source-of-distribution report showing interest collected versus reserve draws versus new capital inflows, broken out per loan or at least in aggregate. A fund unwilling to provide that level of reporting is telling an LP something important on its own.